The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

As per The Business Research Company’s Non Alcoholic Steatohepatitis Treatment Global Market Report 2023, the non alcoholic steatohepatitis treatment market is expected to show significant growth in the forecast period.

Key insights from the non alcoholic steatohepatitis treatment market forecast include:

1. Market Size

The global non alcoholic steatohepatitis treatment market is expected to grow from $1.36 billion in 2022 to $1.89 billion in 2023 at a compound annual growth rate (CAGR) of 38.7%. The non-alcoholic steatohepatitis treatment market size is expected to reach $6.87 billion in 2027 at a CAGR of 38.1%.

2. Major Driver

The rising prevalence of insulin resistance has fueled the future expansion of the non-alcoholic steatohepatitis treatment industry. According to a report from the International Diabetes Federation, a global diabetes community located in Belgium, diabetes affects 537 million people (20-79 years old), accounting for one out of every ten, and is anticipated to rise to 643 million by 2030 and 783 million by 2045. Furthermore, according to gov.UK, a United Kingdom public sector information website, the rate of early death owing to liver illness increased significantly in 2020 compared to 2019. As a result, the market for non-alcoholic steatohepatitis treatment will be driven by a rise in the prevalence of insulin resistance caused by numerous liver and diabetes illnesses.

View More On The Non Alcoholic Steatohepatitis Treatment Market Report 2023 – https://www.thebusinessresearchcompany.com/report/non-alcoholic-steatohepatitis-treatment-global-market-report

3. Key Trend

The development of a non-alcoholic steatohepatitis (NASH) medicine is a major trend that is gaining traction in the non-alcoholic steatohepatitis treatment market. Many businesses are investing in the development of novel medications for the treatment of liver illnesses that have fewer negative effects. For example, in May 2022, Pfizer Inc., an American pharmaceutical and biotechnology company, was granted fast-track designation by the US Food and medications Administration (FDA) to speed the development of the non-alcoholic steatohepatitis (NASH) medications ervogastat and clesacostat. Fast Track is a process designed to Pfizer’s investigational combination therapy for the treatment of non-alcoholic steatohepatitis (NASH) with liver fibrosis named as; ervogastat (PF-06865571, a diacylglycerol O-acyltransferase 2 inhibitor, or DGAT2i) and clesacostat (PF-05221304, an acetyl-CoA carboxylase inhibitor, or ACCi).

4. Largest Region

North America was the largest region in the non-alcoholic steatohepatitis treatment market in 2022.

5. Major Players

Major players in the food diagnostics market are AstraZeneca Plc., Tobira Therapeutics Inc., Galmed Pharmaceuticals, Genfit SA, Zydus Cadila, Bristol Myers Squibb, Gilead Science, Conatus Pharmaceuticals Inc., Novo Nordisk A/S, Immuron Ltd., Raptor Pharmaceutical Corporation, Inventiva Pharma, NGM Biopharmaceuticals Inc., Galectin Therapeutics Inc., Madrigal Pharmaceuticals, and Gemphire Therapeutics.

Request A Sample Of The Global Non Alcoholic Steatohepatitis Treatment Market Report 2023:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8595&type=smp

Key Non Alcoholic Steatohepatitis Treatment Market Segments

The global non alcoholic steatohepatitis treatment market is segmented –

1) By Drug Type: Vitamin E And Pioglitazone, Ocaliva, Elafibranor, Selonsertib And cenicriviroc, Obeticholic Acid, Other Drugs Types

2) By Test Type: Blood Tests, Liver Biopsy, Imaging Procedures

3) By End User: Hospital Pharmacies, Retail And Specialty Pharmacies, Other End Users

The Non Alcoholic Steatohepatitis Treatment Global Market Report 2023  provides an in-depth analysis on the non alcoholic steatohepatitis treatment market size, trends and drivers, opportunities, strategies, and companies analysis. The countries covered in the non alcoholic steatohepatitis treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

View More Related Reports –
Alcoholic – Beverages Global Market Report 2023
Non Alcoholic – Beverages Global Market Report 2023
Psoriatic Arthritis Treatment Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model